These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 18107517)

  • 1. Human prothrombin; quantitative studies on the plasma labile factor and the restorative effects of normal, hypofibrinogenemic, and hemophilic plasma on the prothrombin of stored plasma.
    ALEXANDER B; DE VRIES A
    J Clin Invest; 1949 Jan; 28(1):24-31. PubMed ID: 18107517
    [No Abstract]   [Full Text] [Related]  

  • 2. HUMAN PROTHROMBIN: QUANTITATIVE STUDIES ON THE PLASMA LABILE FACTOR AND THE RESTORATIVE EFFECTS OF NORMAL, HYPOFI-BRINOGENEMIC, AND HEMOPHILIC PLASMA ON THE PROTHROMBIN OF STORED PLASMA.
    Alexander B; De Vries A; Addelson E
    J Clin Invest; 1949 Jan; 28(1):24-31. PubMed ID: 16695655
    [No Abstract]   [Full Text] [Related]  

  • 3. The assay and properties of labile factor (factor V).
    QUICK AJ
    J Clin Pathol; 1960 Nov; 13(6):457-62. PubMed ID: 13738700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stability of prothrombin and Ac-globulin in stored human plasma as influenced by conditions of storage.
    FAHEY JL; WARE AG; SEEGERS WH
    Am J Physiol; 1948 Jul; 154(1):122-33. PubMed ID: 18893069
    [No Abstract]   [Full Text] [Related]  

  • 5. The labile factor of prothrombin conversion: its consumption under normal and pathological conditions affecting blood coagulation.
    ALEXANDER B; GOLDSTEIN R; LANDWEHR G
    J Clin Invest; 1951 Mar; 30(3):252-62. PubMed ID: 14824275
    [No Abstract]   [Full Text] [Related]  

  • 6. The concentration of the labile factor of the prothrombin complex in human, dog, and rabbit blood; its significance in the determination of prothrombin activity.
    QUICK AJ; STEFANINI M
    J Lab Clin Med; 1948 Jul; 33(7):819-26. PubMed ID: 18869568
    [No Abstract]   [Full Text] [Related]  

  • 7. The concentration of the labile factor of prothrombin in the blood of various species.
    STEFANINI M; QUICK AJ
    Fed Proc; 1948 Mar; 7(1 Pt 1):191. PubMed ID: 18938817
    [No Abstract]   [Full Text] [Related]  

  • 8. [The A factor and labile factor of the prothrombin complex and Howell's time in cirrhosis of the liver].
    GIANNICO O; MARRAZZA P
    Riforma Med; 1950 Apr; 64(13):356-8. PubMed ID: 15424591
    [No Abstract]   [Full Text] [Related]  

  • 9. The stability of Ac-globulin and of prothrombin in citrated human plasma.
    FAHEY JL; WARE AG; SEEGERS WH
    Surg Gynecol Obstet; 1949 Mar; 88(3):370-2. PubMed ID: 18111783
    [No Abstract]   [Full Text] [Related]  

  • 10. Human prothrombin metabolism in normal man and in hypocoagulable subjects.
    Shapiro SS; Martinez J
    J Clin Invest; 1969 Jul; 48(7):1292-8. PubMed ID: 5794251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparin and low molecular weight heparins inhibit prothrombinase formation but not its activity in plasma.
    Ofosu FA; Lormeau JC; Craven S; Dewar L; Anvari N
    Thromb Haemost; 1994 Dec; 72(6):862-8. PubMed ID: 7740455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [CHANGES IN THE ACTIVITY OF INDIVIDUAL FACTORS OF THE PROTHROMBIN COMPLEX IN AGING OF THE PLASMA].
    MARES J; PODLIPNY J
    Z Arztl Fortbild (Jena); 1964 Jun; 58():655-8. PubMed ID: 14241491
    [No Abstract]   [Full Text] [Related]  

  • 13. The powerful urinary procoagulant and its relation to renal diseases.
    von Kaulla KN; von Kaulla E
    Curr Probl Clin Biochem; 1979; (9):342-55. PubMed ID: 446080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [AC globulin and SPCA: two plasma factors in the conversion of prothrombin; clinical and biological study and review].
    ALEXANDER B
    Rev Hematol; 1952; 7(2):168-227. PubMed ID: 14958229
    [No Abstract]   [Full Text] [Related]  

  • 15. Influence of time and temperature on coagulation analytes in stored plasma.
    Heil W; Grunewald R; Amend M; Heins M
    Clin Chem Lab Med; 1998 Jun; 36(7):459-62. PubMed ID: 9746270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PLASMA THROMBOPLASTIN COMPONENT (PTC) DEFICIENCY: A CASE REPORT.
    IDA M; TANAKA M
    Shonika Kiyo; 1963; 9():297-301. PubMed ID: 14112922
    [No Abstract]   [Full Text] [Related]  

  • 17. A whole-blood homogeneous assay for the multiplex detection of the factor V G1691A and the prothrombin G20210A mutations.
    Hobson-Peters J; Toye P
    Mol Cell Probes; 2005 Aug; 19(4):290-7. PubMed ID: 16006096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The procoagulant effect of platelets on conversion of prothrombin to thrombin in nonanticoagulated plasma.
    White BN; Cox AC; Taylor FB
    J Lab Clin Med; 1980 Jun; 95(6):827-41. PubMed ID: 7381294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Quantitative relationship between clotting factors V and VII in prothrombin conversion].
    WITTE S; DIRNBERGER P
    Acta Haematol; 1953 Jun; 9(6):380-8. PubMed ID: 13079572
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhibition of prothrombin activation by bothrojaracin, a C-type lectin from Bothrops jararaca venom.
    Monteiro RQ; Zingali RB
    Arch Biochem Biophys; 2000 Oct; 382(1):123-8. PubMed ID: 11051105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.